Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New advances in ovulation induction.

Souzan Kafy1, Togas Tulandi

  • 1Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.

Current Opinion in Obstetrics & Gynecology
|May 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The mTOR/AMPK signaling axis in placental dysfunction and preeclampsia: mechanisms and therapeutic targeting with metformin.

Molecular biology reports·2026
Same author

The endothelin-1/TLR4/NF-κB/NLRP3 inflammasome axis in preeclampsia: a review of a pathological feed-forward loop and therapeutic frontier.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

The Protective Effect of Quercetin Against Zinc Oxide Nanoparticles Induced Placental Toxicity in Rats by Inhibiting Oxidative Stress, ER Stress, and Apoptosis.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2026
Same author

Response: Gynecologic surgery for benign disease: Preserving reproductive potential.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Lean Polycystic Ovarian Syndrome Has Better Responses toRecombinant Follicle-Stimulating Hormone Compared to ObesePCOS during Ovarian Stimulation for <i>In Vitro</i> Fertilization:A Cross-Sectional Study.

International journal of fertility & sterility·2026
Same author

Global Review on the Use of AI in IVF Laboratories.

Journal of obstetrics and gynaecology of India·2026

Aromatase inhibitors like letrozole are effective alternatives for ovulation induction, offering improved pregnancy rates and endometrial thickness compared to clomiphene citrate. They are a cost-effective option, with similar safety profiles for congenital malformations.

Area of Science:

  • Reproductive Endocrinology
  • Pharmacology

Background:

  • Ovulation induction is a key treatment for infertility.
  • Clomiphene citrate and gonadotropins are established therapies.

Purpose of the Study:

  • To review recent advancements in ovulation induction therapies.
  • To evaluate the efficacy and safety of aromatase inhibitors.

Main Methods:

  • Literature review of recent studies on ovulation induction.
  • Comparative analysis of aromatase inhibitors, clomiphene citrate, and gonadotropins.

Main Results:

  • Aromatase inhibitors, particularly letrozole (5 mg daily for 5 days), show comparable efficacy to gonadotropins but are less expensive.
  • Letrozole use is associated with improved endometrial thickness and pregnancy rates versus clomiphene citrate.

Related Experiment Videos

  • Combination therapy with letrozole and gonadotropins reduces gonadotropin dosage while maintaining pregnancy rates.

    • Conclusions:

    • Aromatase inhibitors represent a viable alternative to clomiphene citrate and gonadotropins for ovulation induction and superovulation.
    • Letrozole offers a favorable balance of efficacy, cost, and safety in ovulation induction.